Pink SheetContract research, development and manufacturing organizations (CRDMOs) across the world are keenly watching US President Donald Trump’s moves in the world’s largest pharmaceutical market. Manni Kanti
ScripJohnson & Johnson’s blockbuster psoriasis drug Tremfya (guselkumab) has received approval from the European Commission (EC) for the treatment of adult patients with moderately to severely active u
ScripRevolution Medicines has strengthened its chances of becoming a leader in KRAS-targeting drugs with new Phase I results from zoldonrasib in non-small cell lung cancer (NSCLC). Analysts think the new m
Pink SheetHospital systems Bon Secours Mercy Health and the Cleveland Clinic told Senate investigators that they do not pass 340B drug discounts directly to patients because Congress did not design the 340B pro